Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

2 records – page 1 of 1.

BCCA Research Faculty town hall meeting

https://bccalibrary.andornot.com/en/permalink/catalog18217
BC Cancer Research Centre. [Vancouver, BC?]: BC Cancer Agency. Multi-Media Services , 2009.
Audience
Professional
Call Number
QZ200 B365b 2009
Availability
1 copy, 1 available
Introduce Doug Nelson, CEO of BC Cancer Foundation; Update from BCCA Research Advisory Group (BRAG) - New committees; BCCA research review 2011; Scientists salary process; Director, Office of Research Facilitation; BCCRC website launch; Other items
More Information
Corporate Author
BC Cancer Research Centre
Place of Publication
[Vancouver, BC?]
Publisher
BC Cancer Agency. Multi-Media Services
Publication Date
2009
Physical Description
60 minutes
Subjects
Biomedical Research - organization & administration
BCCA
BCCRC
Cancer Care Facilities
Research Support as Topic
Research Personnel - organization & administration
Abstract
Introduce Doug Nelson, CEO of BC Cancer Foundation
Update from BCCA Research Advisory Group (BRAG) - New committees; BCCA research review 2011; Scientists salary process; Director, Office of Research Facilitation
BCCRC website launch
Other items
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Vancouver Library AV Room
Call Number
QZ200 B365b 2009

Copies

c.1 BC Cancer Agency VAN Library AV Room Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less